Citigroup’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $597K | Sell |
|
|||||
|
2025
Q2 | $1.14M | Buy |
|
|||||
|
2025
Q1 | $236K | Buy |
|
|||||
|
2024
Q4 | $253K | Buy |
|
|||||
|
2024
Q3 | $144K | Sell |
|
|||||
|
2024
Q2 | $150K | Buy |
|
|||||
|
2024
Q1 | $104K | Sell |
|
|||||
|
2023
Q4 | $138K | Buy |
|
|||||
|
2023
Q3 | $97.9K | Sell |
|
|||||
|
2023
Q2 | $160K | Sell |
|
|||||
|
2023
Q1 | $280K | Buy |
|
|||||
|
2022
Q4 | $71.3K | Buy |
|
|||||
|
2022
Q3 | $62K | Sell |
|
|||||
|
2022
Q2 | $58K | Sell |
|
|||||
|
2022
Q1 | $3.13M | Buy |
|
|||||
|
2021
Q4 | $72K | Sell |
|
|||||
|
2021
Q3 | $40K | Sell |
|
|||||
|
2021
Q2 | $56K | Buy |
|
|||||
|
2021
Q1 | $17K | Sell |
|
|||||
|
2020
Q4 | $22K | Buy |
|
|||||
|
2020
Q3 | $3K | Sell |
|
|||||
|
2020
Q2 | $62K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $18K | Buy |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $10K | Buy |
|
|||||
|
2019
Q1 | $8K | Buy |
|
|||||
|
2018
Q4 | $4K | Hold |
|
|||||
|
2018
Q3 | $8K | Sell |
|
|||||
|
2018
Q2 | $6K | Hold |
|
|||||
|
2018
Q1 | $3K | Hold |
|
|||||
|
2017
Q4 | $2K | Hold |
|
|||||
|
2017
Q3 | $2K | Hold |
|
|||||
|
2017
Q2 | $2K | Hold |
|
|||||
|
2017
Q1 | $3K | Hold |
|
|||||
|
2016
Q4 | $5K | Hold |
|
|||||
|
2016
Q3 | $6K | Hold |
|
|||||
|
2016
Q2 | $4K | Hold |
|
|||||
|
2016
Q1 | $5K | Hold |
|
|||||
|
2015
Q4 | $6K | Hold |
|
|||||
|
2015
Q3 | $6K | Buy |
|
|||||
|
2015
Q2 | $1K | Buy |
|